168 related articles for article (PubMed ID: 38396948)
1. The Interaction of the Endocannabinoid Anandamide and Paracannabinoid Lysophosphatidylinositol during Cell Death Induction in Human Breast Cancer Cells.
Akimov MG; Gretskaya NM; Gorbacheva EI; Khadour N; Chernavskaya VS; Sherstyanykh GD; Kovaleko TF; Fomina-Ageeva EV; Bezuglov VV
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396948
[TBL] [Abstract][Full Text] [Related]
2. Anandamide inhibits FcεRI-dependent degranulation and cytokine synthesis in mast cells through CB
Cruz SL; Sánchez-Miranda E; Castillo-Arellano JI; Cervantes-Villagrana RD; Ibarra-Sánchez A; González-Espinosa C
Int Immunopharmacol; 2018 Nov; 64():298-307. PubMed ID: 30243065
[TBL] [Abstract][Full Text] [Related]
3. Analysis of anandamide- and lysophosphatidylinositol-induced inhibition of the vasopressor responses produced by sympathetic stimulation or noradrenaline in pithed rats.
Marichal-Cancino BA; Manrique-Maldonado G; Altamirano-Espinoza AH; Ruiz-Salinas I; González-Hernández A; Maassenvandenbrink A; Villalón CM
Eur J Pharmacol; 2013 Dec; 721(1-3):168-77. PubMed ID: 24076186
[TBL] [Abstract][Full Text] [Related]
4. The endocannabinoids anandamide and virodhamine modulate the activity of the candidate cannabinoid receptor GPR55.
Sharir H; Console-Bram L; Mundy C; Popoff SN; Kapur A; Abood ME
J Neuroimmune Pharmacol; 2012 Dec; 7(4):856-65. PubMed ID: 22454039
[TBL] [Abstract][Full Text] [Related]
5. Anandamide-induced endoplasmic reticulum stress and apoptosis are mediated by oxidative stress in non-melanoma skin cancer: Receptor-independent endocannabinoid signaling.
Soliman E; Van Dross R
Mol Carcinog; 2016 Nov; 55(11):1807-1821. PubMed ID: 26513129
[TBL] [Abstract][Full Text] [Related]
6. [Anandamide inhibits the growth of colorectal cancer cells through CB1 and lipid rafts].
Liao YS; Wu J; Wang P; Zhang H
Zhonghua Zhong Liu Za Zhi; 2011 Apr; 33(4):256-9. PubMed ID: 21575494
[TBL] [Abstract][Full Text] [Related]
7. Anandamide modulates human sperm motility: implications for men with asthenozoospermia and oligoasthenoteratozoospermia.
Amoako AA; Marczylo TH; Marczylo EL; Elson J; Willets JM; Taylor AH; Konje JC
Hum Reprod; 2013 Aug; 28(8):2058-66. PubMed ID: 23697839
[TBL] [Abstract][Full Text] [Related]
8. The major endocannabinoid anandamide (AEA) induces apoptosis of human granulosa cells.
Costa L; Moreia-Pinto B; Felgueira E; Ribeiro A; Rebelo I; Fonseca BM
Prostaglandins Leukot Essent Fatty Acids; 2021 Aug; 171():102311. PubMed ID: 34126378
[TBL] [Abstract][Full Text] [Related]
9. Characterization of anandamide-stimulated cannabinoid receptor signaling in human ULTR myometrial smooth muscle cells.
Brighton PJ; McDonald J; Taylor AH; Challiss RA; Lambert DG; Konje JC; Willets JM
Mol Endocrinol; 2009 Sep; 23(9):1415-27. PubMed ID: 19477951
[TBL] [Abstract][Full Text] [Related]
10. The endocannabinoid anandamide induces apoptosis in cytotrophoblast cells: involvement of both mitochondrial and death receptor pathways.
Costa MA; Fonseca BM; Teixeira NA; Correia-da-Silva G
Placenta; 2015 Jan; 36(1):69-76. PubMed ID: 25465706
[TBL] [Abstract][Full Text] [Related]
11. The endocannabinoid anandamide causes endothelium-dependent vasorelaxation in human mesenteric arteries.
Stanley CP; Hind WH; Tufarelli C; O'Sullivan SE
Pharmacol Res; 2016 Nov; 113(Pt A):356-363. PubMed ID: 27633407
[TBL] [Abstract][Full Text] [Related]
12. Anticancer activity of anandamide in human cutaneous melanoma cells.
Adinolfi B; Romanini A; Vanni A; Martinotti E; Chicca A; Fogli S; Nieri P
Eur J Pharmacol; 2013 Oct; 718(1-3):154-9. PubMed ID: 24041928
[TBL] [Abstract][Full Text] [Related]
13. Glycerophosphodiesterase 3 (GDE3) is a lysophosphatidylinositol-specific ectophospholipase C acting as an endocannabinoid signaling switch.
Briand-Mésange F; Pons V; Allart S; Masquelier J; Chicanne G; Beton N; Payrastre B; Muccioli GG; Ausseil J; Davignon JL; Salles JP; Chap H
J Biol Chem; 2020 Nov; 295(46):15767-15781. PubMed ID: 32917725
[TBL] [Abstract][Full Text] [Related]
14. FAAH inhibition enhances anandamide mediated anti-tumorigenic effects in non-small cell lung cancer by downregulating the EGF/EGFR pathway.
Ravi J; Sneh A; Shilo K; Nasser MW; Ganju RK
Oncotarget; 2014 May; 5(9):2475-86. PubMed ID: 24811863
[TBL] [Abstract][Full Text] [Related]
15. Antiangiogenic activity of the endocannabinoid anandamide: correlation to its tumor-suppressor efficacy.
Pisanti S; Borselli C; Oliviero O; Laezza C; Gazzerro P; Bifulco M
J Cell Physiol; 2007 May; 211(2):495-503. PubMed ID: 17192847
[TBL] [Abstract][Full Text] [Related]
16. Palmitoylethanolamide inhibits the expression of fatty acid amide hydrolase and enhances the anti-proliferative effect of anandamide in human breast cancer cells.
Di Marzo V; Melck D; Orlando P; Bisogno T; Zagoory O; Bifulco M; Vogel Z; De Petrocellis L
Biochem J; 2001 Aug; 358(Pt 1):249-55. PubMed ID: 11485574
[TBL] [Abstract][Full Text] [Related]
17. Anandamide induces cell death through lipid rafts in hepatic stellate cells.
Yang Q; Liu HY; Zhang YW; Wu WJ; Tang WX
J Gastroenterol Hepatol; 2010 May; 25(5):991-1001. PubMed ID: 20059638
[TBL] [Abstract][Full Text] [Related]
18. Anandamide capacitates bull spermatozoa through CB1 and TRPV1 activation.
Gervasi MG; Osycka-Salut C; Caballero J; Vazquez-Levin M; Pereyra E; Billi S; Franchi A; Perez-Martinez S
PLoS One; 2011 Feb; 6(2):e16993. PubMed ID: 21347292
[TBL] [Abstract][Full Text] [Related]
19. The endocannabinoid anandamide activates pro-resolving pathways in human primary macrophages by engaging both CB
Leuti A; Fava M; Forte G; Pellegrini N; Oddi S; Scipioni L; Gomez EA; Dalli J; Maccarrone M
FASEB J; 2024 May; 38(10):e23675. PubMed ID: 38801406
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of fatty acid amide hydrolase activates Nrf2 signalling and induces heme oxygenase 1 transcription in breast cancer cells.
Li H; Wood JT; Whitten KM; Vadivel SK; Seng S; Makriyannis A; Avraham HK
Br J Pharmacol; 2013 Oct; 170(3):489-505. PubMed ID: 23347118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]